Text: H.R.4882 — 108th Congress (2003-2004)All Bill Information (Except Text)

There is one version of the bill.

Bill text available as:

Shown Here:
Introduced in House (07/21/2004)


Formatting necessary for an accurate reading of this legislative text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF or HTML/XML.




[Congressional Bills 108th Congress]
[From the U.S. Government Printing Office]
[H.R. 4882 Introduced in House (IH)]






108th CONGRESS
  2d Session
                                H. R. 4882

  To amend the Controlled Substances Import and Export Act to provide 
   authority to the Attorney General to authorize narcotic drugs in 
  schedule I, II, III, or IV and nonnarcotic controlled substances in 
schedule I or II to be exported from the United States to a country for 
  subsequent export from that country to another country, if certain 
                          conditions are met.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 21, 2004

 Mr. Pitts (for himself, Mr. Brown of Ohio, Mr. Greenwood, Ms. Eshoo, 
   Mr. Deal of Georgia, Mr. Gerlach, Mr. Weldon of Pennsylvania, Mr. 
    Cannon, Mr. Matheson, Mr. Houghton, Mr. Bishop of Utah, and Mr. 
 Cunningham) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
  To amend the Controlled Substances Import and Export Act to provide 
   authority to the Attorney General to authorize narcotic drugs in 
  schedule I, II, III, or IV and nonnarcotic controlled substances in 
schedule I or II to be exported from the United States to a country for 
  subsequent export from that country to another country, if certain 
                          conditions are met.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Controlled Substances Export Reform 
Act of 2004''.

SEC. 2. REEXPORTATION OF CONTROLLED SUBSTANCES.

    Section 1003 of the Controlled Substances Import and Export Act (21 
U.S.C. 953) is amended by adding at the end the following subsection:
    ``(f) Notwithstanding subsections (a)(4) and (c)(3), the Attorney 
General may authorize any narcotic drug in schedule I, II, III, or IV 
or any nonnarcotic controlled substance in schedule I or II (which drug 
or substance is referred to in this subsection as a `covered drug') to 
be exported from the United States to a country for subsequent export 
from that country to another country, if each of the following 
conditions is met:
            ``(1) Both the country to which the covered drug is 
        exported from the United States (referred to in this subsection 
        as the `first country') and the country to which the drug is 
        exported from the first country (referred to in this section as 
        the `second country') are parties to the Conventions referred 
        to in subsections (a)(1)(C) and (e)(3).
            ``(2) The first country and the second country have each 
        instituted and maintain, in conformity to such Conventions, a 
        system of controls of imports of controlled substances which 
        the Attorney General deems adequate.
            ``(3) With respect to the first country, the covered drug 
        is consigned to a holder of such permits or licenses as may be 
        required under the laws of such country, and a permit or 
        license to import the drug has been issued by the country.
            ``(4) With respect to the second country, substantial 
        evidence is furnished to the Attorney General by the person who 
        will export the covered drug from the United States that--
                    ``(A) the drug is to be consigned to a holder of 
                such permits or licenses as may be required under the 
                laws of such country, and a permit or license to import 
                the drug is to be issued by the country;
                    ``(B) there is an actual need for the drug for 
                medical, scientific, or other legitimate uses within 
                the country; and
                    ``(C) the drug will not be exported from the 
                country.
            ``(5) Within 30 days after the covered drug is exported 
        from the first country to the second country, the person who 
        exported the drug from the United States delivers to the 
        Attorney General documentation certifying that such export from 
        the first country has occurred.
            ``(6) A permit to export the covered drug from the United 
        States has been issued by the Attorney General.''.
                                 <all>